Epimedix Inc is a Noncommercial Research Organizations business in Washington, DC.
| Business Name: | Epimedix Inc |
| Categorized In: | Noncommercial Research Organizations |
| Address: | 700 East St Se, Washington, DC 20003 |
| Phone Number: | (202) 547-9180 |
| Contact Person: | Jeff Perlman |
| NAICS Code: | 541720 |
| SIC Code: | 8733 |
| Business Type: | B2B (Business to Business) |
| Employee #: | 1 to 4 |
| Location Type: | Branch |
| Annual Revenue ($): | Unknown |
| Share This Business: | |
| Similar Businesses: |
Climate Institute - Washington, DC 20003 Leonardo Neher - Washington, DC 20003 Luehrs R&A LLC - Washington, DC 20003 Jefferson Institute - Washington, DC 20003 Michael Barry - Washington, DC 20003 Declaration Foundation - Washington, DC 20003 Jeffrey A Cutler - Washington, DC 20003 US China Policy Foundation - Washington, DC 20003 Selous Foundation - Washington, DC 20003 Joyce H Berry Phd - Washington, DC 20003 Congressional Institute - Washington, DC 20003 Open Space Institute Inc - Washington, DC 20003 |
Epimedix Inc, a stable growing company under Noncommercial Research Organizations, is being run by Jeff Perlman. Since , their sales have been favorable and consistent at Unknown. Company location coordinates are: 38.882854,-76.99598.
It can be reached by dialing (202) 547-9180, and you could get in touch with their sales team in 700 East St Se, Washington, District of Columbia DC 20003. Visit their website at: to know more about the company’s history, products and services, as well as frequently asked questions and privacy policies.
Special deals are also offered from time to time. Their professional and honest business transactions fortifies both consumers and businesses in their B2B segments.
Their modest but solid branch houses 1 to 4 staff members. All are benefiting from the company’s generous programs and sound training solutions.
You can learn more by checking their classification codes: SIC – 8733 and NAIC – 541720. Call the hotline stated above for faster transaction and queries. Epimedix Inc would like to hear from you.